Anixa Biosciences's total assets for Q4 2025 were $16.08M, a decrease of -8.90% from the previous quarter. ANIX total liabilities were $2.13M for the fiscal quarter, a -4.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.